Literature DB >> 10211166

Medication received by patients with depression following the acute episode: adequacy and relation to outcome.

R Ramana1, E S Paykel, P G Surtees, D Melzer, M A Mehta.   

Abstract

BACKGROUND: The adequacy of pharmacotherapy received in practice by patients after an acute episode of depression has been little studied. AIMS: To describe and assess adequacy of drug continuation and maintenance in patients with depression.
METHOD: Patients with depression were interviewed 18 months after discharge from hospital. Quantitative assessments of drug treatment doses and compliance were made monthly over this period, and qualitative ratings in continuation and maintenance phases.
RESULTS: About 20% of patients were prescribed low drug doses after discharge and 10% were prescribed no drugs at all. Reported compliance was around 70%. About 30% failed to receive adequate longer-term treatment, mostly due to the continuation phase being too short. Deficiencies of dosage and compliance were greater in patients who never achieved full recovery. Patient refusal was the most common reason for not using antidepressants. Further episodes of depression were not particularly associated with inadequate treatment.
CONCLUSIONS: There were deficiencies in drug treatment that did not appear to be the principal cause of further episodes but may be important in non-recovery. Patient fears require discussion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211166     DOI: 10.1192/bjp.174.2.128

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  2 in total

1.  Patterns of antidepressant prescriptions : ii continuation phase treatments.

Authors:  S Chakrabarti; P Kulhara
Journal:  Indian J Psychiatry       Date:  2000-01       Impact factor: 1.759

2.  An approach to maximizing treatment adherence of children and adolescents with psychotic disorders and major mood disorders.

Authors:  Robin Edward Gearing; Irfan A Mian
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2005-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.